CKD Bio Corp operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CKD Bio Corp with three other
companies in this sector in South Korea:
Kolon Life Science Incorporation
sales of 132.68 billion Korean Won [US$112.51 million]
of which 49%
was Environment Material),
Ctc Bio, Incorporation.
(138.40 billion Korean Won [US$117.36 million]
of which 74%
was Animal Medication), and
Hwail Pharmaceutical Company Limited
(102.07 billion Korean Won [US$86.56 million]
CKD Bio Corp reported sales of 124.51 billion Korean Won (US$105.58 million)
December of 2018.
increase of 5.3%
versus 2017, when the company's sales were 118.19 billion Korean Won.
Sales at CKD Bio Corp have increased during each of the previous five years
(and since 2013, sales have increased a total of 24%).